Impact on FQHCs

Thoughtful middle aged 60s woman in eyeglasses reading paper letter carefully. Pensive focused older mature retired lady looking at correspondence sheet. considering bank notification at home.

Big Pharma’s push to cut 340B will reduce services for low-income patients, harm local healthcare and cost states billions. This greed will raise drug prices, worsen health disparities, and strain communities. See the state-by-state impact and join the fight to protect 340B.

To counter PhRMA’s misinformation, Genesis partnered with The Sage Policy Group to analyze the proposed 340B cuts’ economic impact on patients and FQHCs nationwide and by state.

At 48 I was facing heart disease, diabetes, and hypertension, forcing me onto disability. Thanks to Specialty Case Management and the 340B program at Genesis, I received coordinated care, affordable medications, and lifestyle coaching that helped stabilize my health. I’m now back at work and supporting my family again.
Armin